Sign In
4 Nov 2015 13:12
Ap27
FORM 38.5(b)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY
1. KEY INFORMATION
Name of exempt principal trader | (GS) GOLDMAN SACHS INTERNATIONAL |
Company dealt in | PFIZER INC |
Class of relevant security to which the dealings being disclosed relate (Note 1) | USD ordinary & GDR |
Date of dealing | 03 November 2015 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)
Long | Short | |||||
Number | (%) | Number | (%) | |||
(1) Relevant securities | 6,890,866 (0.11) | 363,073 (0.00) | ||||
(2) Derivatives (other than options) | 0 (0.00) | 0 (0.00) | ||||
(3) Options and agreements to purchase/sell | 0 (0.00) | 0 (0.00) | ||||
Total | 6,890,866 (0.11) | 363,073 (0.00) | ||||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)
Class of relevant security: | Long | Short | ||||
Number | (%) | Number | (%) | |||
(1) Relevant securities | ||||||
(2) Derivatives (other than options) | ||||||
(3) Options and agreements to purchase/sell | ||||||
Total | ||||||
Ap28
3. DEALINGS (Note 3)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit (Note 4) |
Sale | 80 | 132.4300 BRL |
Sale | 100 | 132.4300 BRL |
Sale | 10,000 | 132.4300 BRL |
Sale | 4,300 | 132.4300 BRL |
Purchase (Borrow New) | 543,649 | N/A |
Sale (Borrow Full Return) | 543,649 | N/A |
Purchase (Loan Partial Return) | 301,233 | N/A |
Purchase (Borrow New) | 332,709 | N/A |
Sale (Borrow Full Return) | 332,709 | N/A |
Sale (Borrow Partial Return) | 819,956 | N/A |
Sale (Borrow Full Return) | 1,032,348 | N/A |
Purchase (Borrow New) | 415,886 | N/A |
Sale (Borrow Full Return) | 415,886 | N/A |
Purchase (Borrow New) | 543,649 | N/A |
Sale (Borrow Full Return) | 543,649 | N/A |
Purchase (Borrow New) | 519,857 | N/A |
Sale (Borrow Full Return) | 519,857 | N/A |
Purchase (Borrow New) | 543,649 | N/A |
Sale (Borrow Full Return) | 543,649 | N/A |
Purchase (Borrow New) | 543,649 | N/A |
Sale (Borrow Full Return) | 543,649 | N/A |
Purchase (Borrow New) | 844,882 | N/A |
Sale (Borrow Full Return) | 844,882 | N/A |
Purchase (Borrow New) | 543,649 | N/A |
Sale (Borrow Full Return) | 543,649 | N/A |
Purchase (Borrow New) | 6,407,576 | N/A |
Purchase (Borrow New) | 543,649 | N/A |
Sale (Borrow Full Return) | 543,649 | N/A |
Purchase (Borrow Adjust) | 20,148 | N/A |
Purchase (Borrow Adjust) | 14,249 | N/A |
Purchase (Borrow Adjust) | 10,343 | N/A |
Purchase (Borrow Adjust) | 6,618 | N/A |
Sale (Borrow Partial Return) | 377 | N/A |
Sale (Borrow Partial Return) | 3,149 | N/A |
Sale (Borrow Partial Return) | 266 | N/A |
Sale (Borrow Partial Return) | 2,227 | N/A |
Sale (Borrow Partial Return) | 193 | N/A |
Sale (Borrow Partial Return) | 1,617 | N/A |
Sale (Borrow Partial Return) | 124 | N/A |
Sale (Borrow Partial Return) | 1,034 | N/A |
Purchase | 3100 | 34.7845 USD |
Purchase | 1400 | 34.7918 USD |
Purchase | 49 | 34.7900 USD |
Purchase | 2800 | 34.7830 USD |
Purchase | 500 | 34.7890 USD |
Purchase | 200 | 34.7850 USD |
Purchase | 500 | 34.7850 USD |
Purchase | 84 | 34.7850 USD |
Purchase | 2150 | 34.7900 USD |
Purchase | 400 | 34.7813 USD |
Purchase | 51 | 34.7850 USD |
Purchase | 400 | 34.7813 USD |
Purchase | 50 | 34.7900 USD |
Purchase | 1000 | 34.7845 USD |
Purchase | 200 | 34.7850 USD |
Purchase | 100 | 34.7850 USD |
Purchase | 100 | 34.7850 USD |
Purchase | 516 | 34.7831 USD |
Purchase | 600 | 34.7850 USD |
Purchase | 100 | 34.7850 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 5) | Number of relevant securities (Note 6) | Price per unit (Note 4) |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 4) |
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 4) |
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Nature of transaction (Note 7) | Details | Price per unit (if applicable) (Note 4) |
Ap29
OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securitiesunder any option referred to on this form or relating to the voting rights or future acquisition
or disposal of any relevant securities to which any derivative referred to on this form is referenced.
If none, this should be stated.
Is a Supplemental Form 38.5(b) attached? (Note 8) YES/NO
Date of disclosure | 04 November 2015 |
Contact name | Aadithya Rao and Yiannis Bardis |
Telephone number | +44(20) 7051 9046 / +44(20) 7774 7107 |
Name of offeree/offeror with which connected | Pfizer Inc |
Nature of connection (Note 9) | Advisor to Offeror |
Follow the stocks
